title: Sexual responses of the male rat medial preoptic area and medial amygdala to estrogen II: site specific effects of selective estrogenic drugs.
abstract: In the medial preoptic area (MPO) and medial amygdala (MEA), estradiol (E(2)) aromatized from testosterone (T) may act via either estrogen receptor (ER) α or ERβ to mediate mating in male rats. We tested the hypothesis that, in the MPO, ERα exclusively mediates sexual responses to E(2) by monitoring mating in four groups of castrated male rats administered dihydrotestosterone (DHT) subcutaneously and MPO implants delivering either: cholesterol, E(2), propyl pyrazole triol (PPT, ERα-agonist) or diarylpropionitrile (DPN, ER β-agonist); a fifth group of intact males served as DPN toxicity control, receiving DPN MPO implants. In a follow-up study, either 1-methyl-4-phenyl pyridinium (MPP, ERα-antagonist) or blank MPO cannulae were implanted in castrated male rats receiving T subcutaneously, whereas intact MPP toxicity controls received MPP MEA implants. PPT or E(2) MPO implants maintained mating, but cholesterol or DPN MPO implants did not. Moreover, MPP MPO implants interfered with T reinstatement of mating suggesting that, in the MPO, ERα is necessary and sufficient for mating in androgen-maintained male rats and ERβ is not sufficient. Because it is unknown which ER subtype(s) mediate sexual responses of the MEA to E(2), we examined mating following MEA implants of cholesterol, E(2), PPT or DPN in four groups of castrated male rats administered DHT subcutaneously. E(2) MEA implants maintained mounting but mating was significantly decreased in groups receiving PPT, DPN or cholesterol MEA implants suggesting that, unlike the MPO where ERα alone is essential, sexual responses of the MEA to E(2) require simultaneous interactions among multiple ER subtypes.
authors.affiliation: Department of Biology, Georgia State University, Atlanta, GA 30302‐4010, USA.
authors.forename: Nancy V
authors.initials: NV
authors.lastname: Russell
authors.forename: Ejiroghene V
authors.initials: EV
authors.lastname: Ogaga-Mgbonyebi
authors.forename: Biniyam
authors.initials: B
authors.lastname: Habteab
authors.forename: Anna I
authors.initials: AI
authors.lastname: Dunigan
authors.forename: Meron A
authors.initials: MA
authors.lastname: Tesfay
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Clancy
mesh_terms: D015655:1-Methyl-4-phenylpyridinium; D000679:Amygdala / Q000187:drug effects / Q000502:physiology*; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D002784:Cholesterol / Q000494:pharmacology; D003307:Copulation / Q000187:drug effects / Q000502:physiology*; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000037:antagonists & inhibitors / Q000502:physiology*; D047629:Estrogen Receptor beta / Q000037:antagonists & inhibitors / Q000502:physiology; D005260:Female; D008297:Male; D009570:Nitriles / Q000494:pharmacology; D009919:Orchiectomy; D010636:Phenols; D011301:Preoptic Area / Q000187:drug effects / Q000502:physiology*; D011422:Propionates / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D013739:Testosterone / Q000494:pharmacology
chemical_list: C486182:2,3-bis(4-hydroxyphenyl)-propionitrile; D000728:Androgens; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D009570:Nitriles; D010636:Phenols; D011422:Propionates; D011720:Pyrazoles; D013196:Dihydrotestosterone; C486184:4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol; D013739:Testosterone; D004958:Estradiol; D002784:Cholesterol; D015655:1-Methyl-4-phenylpyridinium